Rare Disease Field Sales (Dallas)

Ultragenyx•Dallas, TX

1d•Onsite

About The Position

Be a hero for our rare disease patients. At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won’t go – challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments. We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them. Our commitment and care for patients extends to our people, so culture is an essential cornerstone for Ultragenyx. We remain continuously focused on creating a supportive and inclusive environment of profound learning and growth – so employees can thrive in all areas of their lives, in and outside of work. Ultimately, we want to be an organization where we would be proud for our family, friends and children to work. If you want to have a meaningful impact, do the best work of your career, and grow a lot, both professionally and personally, come join our team. We are looking for experienced UltraCare Liaisons (UCLs) that will represent Ultragenyx in the Rare Disease Community, responsible for the promotion of Dojolvi for the treatment of long chain fatty oxidation disorders (LC-FAOD). Ultragenyx is also preparing for the potential commercialization of two investigational novel gene therapies in MPSIIIA and GSD1 a. We are seeking driven individuals with the desire to run their own business within a specified geography. These individuals will have strong business acumen, be able to drive change through innovative approaches, demonstrate excellent communication skills and consistently deliver sales results.

Requirements

Bachelor’s Degree required
8 years with 5+ years being in the healthcare/biotech industry, inclusive of 3 years of field-based experience in account management, sales, and/or field reimbursement.
Documented track record of field sales success
Strategic business acumen and cross-functional and collaborative leadership with internal stakeholders including marketing, medical, clinical operations, and patient services.
Demonstrated experience effectively presenting clinical/scientific information required
Must live in territory geography.

Nice To Haves

Rare disease experience is preferred.
Experience launching biopharma/pharma products successfully is preferred.

Responsibilities

Serve as territory business owner with a focus upon impact and territory analysis.
Optimizing patient diagnosis and care through HCP education.
Educating HCPs about Ultragenyx approved products.
Assisting with treatment fulfillment.
Develop and nurture effective business relationship management with key stakeholders, including HCPs, Registered Dieticians, Genetic Counselors, Pharmacists, and related support staff.
Proactively builds effective working relationships with internal/external stakeholders; can drive agreement/decisions from multiple stakeholders; ability to understand people’s emotions and flex communication style.
Can adjust their approach based on different stakeholder needs, concerns, or audience member to drive alignment and meet their work goals.
Develop and maintain a strategic territory business plan focused on key academic centers, community targets within priority specialties, territory opportunities and challenges.
Determines and implements suitable travel schedule and call plan on a daily/weekly basis to ensure both adequate and highly effective coverage for all key accounts.
Executes programs, high impact in-services, and other educational opportunities for their territory.
Timely completion of compliance trainings, internal product & disease state trainings, Veeva administration, monthly expense reports, and all other administration expectations.